4Indexed trials
drug · Product Intelligence
Bumetanide
Pipeline Intelligence
Bumetanide: 4 indexed trials, 4 sponsors; 4 linked Orange Book patents and 10 FDA-linked events where matched.
4Sponsors
4Orange Book patent links
10FDA-linked events
Development evidence
NCT02947880University Hospital, Limoges · autismPHASE2
NCT03156153Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · autismPHASE2
NCT04766177Sherief Abd-Elsalam · autismPHASE3
NCT07005414Fei Li · autismPHASE2
FDA / patent evidence
12558330ENBUMYST · app 2195002045-05-14
11123319ENBUMYST · app 2195002040-12-04
11260038ENBUMYST · app 2195002040-12-04
12329731ENBUMYST · app 2195002040-12-04
Regulatory context
FDA_APPROVALENBUMYST · 2025-09-12
FDA_APPROVALBUMETANIDE · 2025-02-27
FDA_APPROVALBUMETANIDE · 2024-12-27
FDA_APPROVALBUMETANIDE · 2024-09-18
FDA_APPROVALBUMETANIDE · 2024-09-17
FDA_APPROVALBUMETANIDE · 2023-07-24
FDA_APPROVALBUMETANIDE · 2022-05-26
FDA_APPROVALBUMETANIDE · 1995-04-24
FDA_APPROVALBUMEX · 1985-06-14
FDA_APPROVALBUMEX · 1983-02-28
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.